Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Companies 1/25
Result 44 decisions over 120 months
Reset filters
Minimum amount ? Share of their own holding ?
What the chief executive holds ?
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
15 Sep 2026
President & CEO indirect
Sold on a plan
97,926
$6.79M
100%
30 Jul 2026
EVP, Chief Commercial Officer
Sold on a plan
14,000
$1.12M
19.3%
1 Jul 2026
EVP, Chief Commercial Officer
Sold on a plan
15,000
$1.29M
20.4%
24 Jun 2026
EVP, Chief Financial Officer
Sold on a plan
38,730
$3.19M
38.0%
1 Jun 2026
EVP, Chief Commercial Officer
Sold on a plan
15,000
$1.11M
20.4%
5 May 2026
EVP, Chief Financial Officer
Sold on a plan
23,906
$1.84M
27.4%
5 May 2026
Director
Sold on a plan
20,000
$1.52M
21.0%
1 May 2026
EVP, Chief Commercial Officer
Sold on a plan
15,857
$1.03M
21.3%
17 Mar 2026
President & CEO
Sold at will
36,601
$2.27M
7.8%
5 Mar 2026
EVP, Chief Commercial Officer
Sold on a plan
26,000
$1.61M
34.0%
22 Dec 2025
Director
Sold on a plan
20,000
$1.32M
38.1%
5 Dec 2025
EVP, Chief Commercial Officer
Sold on a plan
52,486
$3.46M
50.9%
1 Dec 2025
Director
Sold on a plan
28,064
$1.87M
73.8%
17 Mar 2025
President & CEO
Sold on a plan
37,648
$1.68M
10.3%
17 Mar 2025
EVP, Chief Commercial Officer
Sold on a plan
23,675
$1.07M
40.4%
13 Mar 2025
EVP, Chief Commercial Officer
Sold on a plan
26,771
$1.17M
41.5%
5 Mar 2025
President & CEO
Sold on a plan
25,000
$1.08M
6.2%
17 Jun 2024
President & CEO
Sold on a plan
22,500
$1.18M
5.1%
4 Jun 2024
President & CEO
Sold on a plan
22,500
$1.10M
4.9%
7 May 2024
EVP Research & Development
Sold on a plan
15,547
$1.01M
10.2%
9 Apr 2024
EVP Research & Development
Sold on a plan
32,605
$2.42M
19.0%
5 Mar 2024
EVP Research & Development
Sold on a plan
32,604
$2.20M
19.0%
6 Feb 2024
EVP Research & Development
Sold on a plan
32,605
$2.59M
18.6%
19 Jan 2024
President & CEO
Sold on a plan
12,500
$1.02M
2.8%
4 Jan 2024
EVP Research & Development
Sold on a plan
15,678
$1.36M
9.6%
2 Jan 2024
President & CEO
Sold on a plan
12,500
$1.06M
2.8%
13 Oct 2022
EVP Research & Development
Sold, plan not stated
21,513
$1.02M
11.3%
12 Sep 2022
Director
Sold, plan not stated
21,759
$1.20M
47.5%
8 Sep 2022
EVP Research & Development
Sold, plan not stated
21,500
$1.12M
11.3%
1 Sep 2022
Director
Sold, plan not stated
30,296
$1.60M
75.2%
10 Mar 2022
EVP Research & Development
Sold, plan not stated
26,852
$1.02M
13.8%
27 Dec 2021
Director
Sold, plan not stated
28,290
$1.30M
80.7%
9 Dec 2021
EVP Research & Development
Sold, plan not stated
29,166
$1.06M
16.3%
19 Nov 2021
Director
Sold, plan not stated
29,032
$1.20M
81.1%
9 Nov 2021
Chief HR & Admin Officer
Sold, plan not stated
45,000
$1.88M
24.5%
8 Nov 2021
Director
Sold, plan not stated
26,468
$1.09M
47.8%
5 Nov 2021
Director
Sold, plan not stated
30,996
$1.24M
86.1%
19 Oct 2021
SVP Finance & CFO
Sold, plan not stated
35,687
$1.28M
40.2%
9 Dec 2020
See Explanaton of Responses
Sold, plan not stated
430,954
$7.76M
48.2%
5 Oct 2020
Director
Sold, plan not stated
50,311
$1.51M
100%
13 Feb 2020
10% owner
Sold, plan not stated
1,072,030
$16.92M
71.6%
11 Dec 2019
10% owner
Bought
118,413
$1.13M
3.4%
10 Dec 2019
10% owner
Bought
223,659
$2.10M
6.7%
31 Aug 2017
SVP Drug Discovery & Early Dev
Sold, plan not stated 15×
118,330
$1.77M
71.8%
Showing 1–44 of 44.